Institutionelle bei Human Genome

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Janus Capital Corporation 9,654,826 $153,511,733
JP Morgan Chase & Company 7,899,679 $125,604,896
AXA Financial, Inc. 4,742,065 $75,398,833
Dresdner Rcm Global Investors LLC 2,759,333 $43,873,394
FMR Corporation (Fidelity Management & Research Corp) 17,801,670 $283,046,553
TCW Group, Inc. (The) 2,349,790 $37,361,661
Morgan Stanley 2,241,778 $35,644,270
Price (T.Rowe) Associates 2,125,380 $33,793,542
Barclays Bank Plc 1,988,276 $31,613,588
Invesco Funds Group, Inc. 1,878,690 $29,871,171

Topliste der investierten Fonds
Fidelity Aggressive Growth Fund 4,299,500 $68,362,050
Fidelity Growth Company Fund 3,370,010 $53,583,159
Fidelity Select Portfolios - Biotechnology 2,693,600 $42,828,240
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 2,461,482 $39,137,563
Janus Enterprise Fund 2,348,765 $37,345,363
Janus Aspen Aggressive Growth Portfolio 1,738,773 $27,646,490
Janus Twenty Fund 1,648,720 $26,214,648
American Aadvantage Large Cap Growth Fund 1,600,000 $25,440,000
Janus Worldwide Fund 1,368,480 $21,758,832
Fidelity Advisor Equity Growth Fund 1,362,400 $21,662,160